|
The U.S.
Food and Drug Administration today announced that it has awarded 21 new clinical
trial research grants totaling more than $23 million over the next four years to
boost the development of products for patients with rare diseases. These new
grants were awarded to principal investigators from academia and industry with
research spanning domestic and international clinical sites.
Read more.
|
